QUEBEC CITY, Feb. 27 /CNW Telbec/ - Victhom Human Bionics Inc. ("Victhom"
(TSX: VHB)), today announced the establishment of the six-member Scientific
Advisory Board (SAB) that will bring broad-ranging scientific expertise to the
Neurobionix division of the Company. Mr. Nader Kameli, Chief Operating Officer
of the Neurobionix division, said: "Every member of our new SAB provides
specific expertise and knowledge to establish Victhom as a world-class leader
in the field of neuromodulation for the restoration and treatment of gait
disorders." He further mentioned, "All members of our SAB will participate
actively in developing the next generation of neuromodulation products to
address gait disorders and are committed to helping us succeed in this
endeavor by bringing proven solutions to patients around the globe".
The SAB's purpose is to assist our technical and scientific teams in
assessing the merit and application of innovative solutions that deliver sound
therapies to patients suffering from gait disorders. This Scientific Advisory
Board collectively brings more than 200 years of experience in the field of
peripheral nerve neuromodulation to Victhom.
Mr. Kameli concluded, "I am proud to have these distinguished scientists
on our side as we develop a portfolio of capabilities into our products and
offer a diverse set of solutions to physicians to treat their patients. It is
obvious from their past and current research that they share our passion for
helping patients with partial paralysis live better and more productive
The members of the SAB are:
Andy Hoffer, Ph.D.
Dr. Hoffer is Professor of Biomedical Physiology and Kinesiology,
Director of the Neurokinesiology Laboratory and Director of the Centre for
Disability Independence Research and Education at Simon Fraser University
(SFU) in Burnaby, British Columbia. Dr. Hoffer received a Ph.D. in biophysics
from Johns Hopkins University for his pioneering design of nerve cuffs for
recording peripheral nerve activity during movement. In 1997, he founded
Neurostream Technologies, a Simon Fraser University spin-off R&D company that
designed the Neurostep(R), the first fully implanted assistive system for
walking in patients with foot drop. In 2004, this technology was acquired by
Victhom and Dr. Hoffer has continued to serve as expert scientific advisor to
Victhom. Dr. Hoffer is a founding member of the International Functional
Electrical Stimulation Society (IFESS) and currently serves on the IFESS Board
Gerald Loeb, M.D.
Dr. Loeb is Professor of Biomedical Engineering and Neurology and
Director of the Medical Device Development Facility at the University of
Southern California. Dr. Loeb was one of the original developers of the
cochlear implant to restore hearing to the deaf and was Chief Scientist for
Advance Bionics Corp. from 1994 to 1999, manufacturers of the Clarion(R)
cochlear implant. Dr. Loeb is a Fellow of the American Institute of Medical
and Biological Engineers. Most of Dr. Loeb's current research is directed
toward sensorimotor control of paralyzed and prosthetic limbs. His research
team developed BION(TM) injectable neuromuscular stimulators and has been
conducting several pilot clinical trials. Other current technologies include
biomimetic tactile sensors, inferential extraction of commands from residual
shoulder motion and spinal-like regulators for coordination of multiactuator
systems. These projects build on Dr. Loeb's long-standing basic research into
the properties and natural activities of muscles, motoneurons, proprioceptors
and spinal reflexes. They constitute one of the testbeds in the NSF
Engineering Research Center on Biomimetic MicroElectronic Systems, for which
Dr. Loeb is Deputy Director.
Douglas McCreery, Ph.D.
Dr. McCreery received the B.Sc. and M.Sc. degrees in Electrical
Engineering and the Ph.D. degree in Biomedical Engineering from the University
of Connecticut in 1966, 1970, and 1975, respectively. He lives in Pasadena,
California, where he is Director of the Neural Engineering Program at
Huntington Medical Research Institutes. His research interests include the
development of neuroprostheses and devices for neuromodulation for the central
nervous system, and the physiologic and histologic effects of electrical
stimulation of the central and peripheral nervous systems.
J. Thomas Mortimer, Ph.D.
Dr. Mortimer has a thirty-three year record of research in electrically
activating the nervous system. This work has been documented in over ninety
publications and seventeen patents. In July of 2002, Dr. Mortimer became
Professor Emeritus at Case Western Reserve University, where he maintains an
office and continues to be very active in teaching. Dr. Mortimer is the
President of Axon Engineering Inc., a company that has commercialized devices
stemming from sponsored research carried out under his direction. The bulk of
the intellectual property at Axon Engineering Inc. was licensed to a very
large biomedical company in 2001. Dr. Mortimer's research efforts have
involved the development of electrodes for neural prostheses and instruments
to implant them. Devices that he has developed include devices used in pain
management, restoration of upper and lower extremity function, respiratory
pacing, visual prosthesis, bowel and bladder assist and scoliosis correction.
Milos Popovic, Ph.D.
Dr. Popovic received the Ph.D. degree in mechanical engineering from the
University of Toronto, Canada in 1996, and the Electrical Engineer degree from
the University of Belgrade, Yugoslavia in 1990. Dr. Popovic is Chair in Spinal
Cord Injury Research at Toronto Rehab. He is also an Associate Professor at
the Institute of Biomaterials and Biomedical Engineering at the University of
Toronto, and Senior Scientist and the Activity Team Leader at Toronto
Rehabilitation Institute, both institutions located in Toronto, Canada. Dr.
Popovic joined the Institute of Biomaterials and Biomedical Engineering and
the Toronto Rehab in 2001. From 1997 until 2001, he was leading the
Rehabilitation Engineering Team at the Swiss Federal Institute of Technology
and the Paraplegic Center of the University Hospital Balgrist, both in Zurich,
Switzerland. Dr. Popovic's fields of expertise are Functional Electrical
Stimulation, neuro-rehabilitation, modeling and control of linear and
non-linear dynamic systems, robotics, power systems, signal processing and
safety analysis. His interests are in the areas of neuro-rehabilitation,
physiological control systems, assistive technology and brain machine
Douglas Weber, Ph.D.
Dr. Weber is Assistant Professor in the Department of Physical Medicine
and Rehabilitation at the University of Pittsburgh. He is also a faculty
member in the Department of Bioengineering and the Center for the Neural Basis
of Cognition. Dr. Weber received a B.S. degree in Biomedical Engineering from
the Milwaukee School of Engineering in 1994, and M.S. and Ph.D degrees in
Bioengineering from Arizona State University in 2000 and 2001. He was a
Postdoctoral Fellow from 2001 to 2003, and Assistant Professor (03-05) in the
Centre for Neuroscience at the University of Alberta before joining the
University of Pittsburgh. His primary research area is Neural Engineering,
including studies of motor learning and control of walking and reaching with
particular emphasis on applications to rehabilitation technologies and
practice. Specific research interests include functional electrical
stimulation, activity-based neuromotor rehabilitation, neural coding, and
neural control of prosthetic devices. Dr. Weber is a member of the Biomedical
Engineering Society, IEEE and IEEE EMBS, and the Society for Neuroscience. Dr.
Weber regularly serves these and other professional societies as a peer
reviewer for several journals in bioengineering, neuroscience, biomechanics,
and rehabilitation medicine.
For a complete biography of all the SAB members, go to
Victhom discovers, develops and manufactures bionic devices involved in
the treatment of a variety of physical and physiological dysfunctions.
Victhom's Neurobionix division focuses on the development and
commercialization of technologies and products involving implantable devices
that feature neurosensing and neurostimulation components, integrated with
artificial intelligence. Victhom's Biotronix division develops biomechatronic
products to support or replace peripheral limbs in what is known as the
orthotics and prosthetics market.
Some of the statements made herein may constitute forward-looking
statements. These statements relate to future events or our future financial
performance and involve known and unknown risks, uncertainties and other
factors that may cause Victhom's actual results, performance or achievements
to be materially different from those expressed or implied by any of Victhom's
statements. Actual events or results may differ materially. We disclaim any
intention, and assume no obligation, to update these forward-looking
For further information:
For further information: Normand Rivard, Acting President, Chief
Financial Officer, Victhom Human Bionics Inc., (418) 872-5665, Fax: (418)
864-7034, email@example.com; www.victhom.com; Source: Victhom Human